Valuation: Compumedics Limited

Market Cap 47.94M 33.73M 30.21M 27.79M 25.18M 47.06M 3.2B 331M 133M 1.68B 127M 124M 5.31B P/E 2027 *
11.4x
P/E 2028 * 7.5x
Enterprise Value 47.94M 33.73M 30.21M 27.79M 25.18M 47.06M 3.2B 331M 133M 1.68B 127M 124M 5.31B EV / Sales 2027 *
0.63x
EV / Sales 2028 * 0.53x
Free-Float
36.04%
Yield 2027 *
-
Yield 2028 * -
1 day+2.13%
3 months+9.09%
6 months-15.79%
Current year-28.36%
1 week 0.23
Extreme 0.23
0.24
1 month 0.23
Extreme 0.23
0.28
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.16
Extreme 0.155
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%0.00%-30.43%+50.00% 33.04M
-1.72%+3.44%+25.31%+60.56% 262B
-2.00%+0.75%+7.99%+25.46% 167B
-3.73%-4.48%-18.49%+67.13% 156B
-1.66%-8.12%-58.26%-16.12% 61.87B
-2.57%+3.30%+10.22%+47.55% 54.44B
0.00%+2.46%-11.97%-6.29% 53.3B
-3.47%+1.04%+21.98%+72.85% 51.07B
+0.84%-3.12%+9.80%+64.47% 50.25B
-3.61%+1.99%+34.94%+95.49% 47.17B
Average -1.58%-0.48%-0.89%+46.11% 90.26B
Weighted average by Cap. -2.12%+0.14%+5.17%+47.96%

Financials

2027 *2028 *
Net sales 75.6M 53.19M 47.63M 43.82M 39.7M 74.21M 5.05B 523M 210M 2.66B 200M 195M 8.38B 91M 64.02M 57.34M 52.74M 47.79M 89.33M 6.08B 629M 252M 3.2B 240M 235M 10.08B
Net income 6M 4.22M 3.78M 3.48M 3.15M 5.89M 401M 41.47M 16.65M 211M 15.84M 15.5M 665M 9.2M 6.47M 5.8M 5.33M 4.83M 9.03M 615M 63.59M 25.53M 323M 24.29M 23.77M 1.02B
Net Debt - -
Projected Income Statement - Annual - Compumedics Limited
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
30/10/26 A$0.2400 +2.13% 3,250
29/10/26 A$0.2350 +2.17% 3,823
28/10/26 A$0.2300 0.00% 5,000
26/10/26 A$0.2300 -4.17% 121,523
23/10/26 A$0.2400 0.00% 70,185
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Compumedics Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2400AUD
Average target price
0.6500AUD
Spread / Average Target
+170.83%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Compumedics Limited